Circulation, Vol 84, 1210-1215, Copyright © 1991 by American Heart Association
PF Binkley, KD Murray, KM Watson, PD Myerowitz and CV Leier
BACKGROUND. The synthetic catecholamine dobutamine increases stroke volume
in normal subjects and in patients with congestive heart failure. In
addition to its direct influence on myocardial contractility, dobutamine
may significantly modulate vascular tone because of its alpha- and
beta-adrenergic agonist activity. METHODS AND RESULTS. To test the
hypothesis that such vasoactive properties significantly contribute to the
improved ventricular performance noted with this agent, hemodynamic
parameters were measured during stepped ascension infusion of dobutamine in
a model that is insensitive to positive inotropic stimulation.
Administration of dobutamine in nine calves that underwent replacement of
the native right and left ventricles with pneumatically driven total
artificial hearts resulted in a significant (p = 0.0001) increase in
cardiac output from 7.0 +/- 1.8 to 8.2 +/- 1.8 l/min and a significant (p =
0.0001) decrease in total peripheral vascular resistance from 1,224 +/- 559
to 745 +/- 317 dyne.sec/cm5. A less marked influence was noted on the
pulmonary vasculature, with pulmonary vascular resistance exhibiting a
significant (p less than 0.05) decrease from its baseline value only at the
peak infusion. Consistent with an increase in venous return, both left and
right atrial pressures increased significantly (p less than 0.005) with
dobutamine administration. CONCLUSIONS. These data demonstrate that the
vasoactive properties of dobutamine significantly contribute to improved
ventricular performance independent of direct myocardial stimulation. This
effect appears to result in part from a direct modulation of myocardial
stimulation. This effect appears to result in part from a direct modulation
of arterial and venous tones rather than from a reflex response to primary
changes in contractility.
ARTICLES
Dobutamine increases cardiac output of the total artificial heart. Implications for vascular contribution of inotropic agents to augmented ventricular function
Division of Cardiology, Ohio State University Hospital, Columbus 43210.
This article has been cited by other articles:
![]() |
D. J. Penny, J. P. Mynard, and J. J. Smolich Aortic wave intensity analysis of ventricular-vascular interaction during incremental dobutamine infusion in adult sheep Am J Physiol Heart Circ Physiol, January 1, 2008; 294(1): H481 - H489. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Uemura, A. Kamiya, I. Hidaka, T. Kawada, S. Shimizu, T. Shishido, M. Yoshizawa, M. Sugimachi, and K. Sunagawa Automated drug delivery system to control systemic arterial pressure, cardiac output, and left heart filling pressure in acute decompensated heart failure J Appl Physiol, April 1, 2006; 100(4): 1278 - 1286. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |